P-148High rates of hepatocellular carcinoma within two years of starting treatment for chronic hepatitis C with direct antiviral agents but not with PEG-interferon/ Ribavirin (HORRID Study). (2nd July 2019) - Karbeyaz, F; Müllhaupt, B; Winder, T; Misselwitz, B; Mertens, J; Siebenhuener, A